Putting the lie once again to notions that PFE moves with the market
Completely amazed at your predictions.
You claimed that Pfizer would beat third quarter estimates and they did as well as being in line to earn in the area of 66B to 67B for 2012 despite the loss of Lipitor. Right on once again with a host of other prognostications you make that seem to baffle many here on this board.
Oh well, when one's intent is to achieve a goal, it's of utmost importance to be up to snuff on all aspects of likelihoods with this Company. You predicted share buybacks, small promising biotech purchases among a host of other accurate forecasts too numerous to mention.
Keep up the good work. We appreciate your dedication to feeding the readers with quality material.